News from canadian generic pharmaceutical association A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 12, 2019, 15:38 ET CGPA Statement on the final report from the Advisory Council on the Implementation of National Pharmacare

TORONTO, June 12, 2019 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the Final Report of the Advisory Council on the...


May 29, 2019, 13:35 ET New Report: Prices of Canadian Generic Medicines Below International Average

PMRPB: Canadian price declines steepest of all OECD countries TORONTO, May 29, 2019 /CNW/ - New data released today by the federal government's Patented Medicine Prices Review Board (PMPRB) shows...


Mar 19, 2019, 18:12 ET CGPA Welcomes Progress Towards National Pharmacare in Federal Budget 2019

TORONTO, March 19, 2019 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on Federal Budget 2019: "The Canadian Generic...


Dec 03, 2018, 09:00 ET Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Less than Half of 10% Commitment

USMCA Concessions Latest Hit to Canadian Prescription Drug Costs TORONTO, Dec. 3, 2018 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada is less...


Oct 01, 2018, 14:44 ET CGPA Statement on Pharmaceutical Concessions in United States-Mexico-Canada Agreement

TORONTO, Oct. 1, 2018 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the pharmaceutical intellectual property aspects of the ...


Sep 24, 2018, 09:00 ET New Poll: Canadians Strongly Agree that Access to Affordable Prescription Medicines is Most Important Priority for NAFTA 2.0

TORONTO, Sept. 24, 2018 /CNW/ - A new poll confirms that Canadians do not want their access to generic and biosimilar medicines traded away under a new NAFTA deal. There are several proposals on the...


Sep 05, 2018, 09:00 ET CGPA Statement on the Resumption of US-Canada Trade Talks

TORONTO, Sept. 5, 2018 /CNW/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the resumption of trade negotiations between the...


Apr 09, 2018, 09:00 ET Peter Hardwick of Apotex Elected Chair of Canadian Generic Pharmaceutical Association

TORONTO, April 9, 2018 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Peter Hardwick, Chief Commercial Officer and Executive Vice...


Jan 29, 2018, 12:30 ET A Joint Statement from the pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association

TORONTO, Jan. 29, 2018 /CNW/ - On behalf of participating federal, provincial, and territorial public drug plans, the pan-Canadian Pharmaceutical Alliance (pCPA), with the Canadian Generic...


Nov 14, 2017, 09:00 ET New Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Less than Half of 10% Commitment

Canada must not concede longer market monopolies in NAFTA discussions TORONTO, Nov. 14, 2017 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada is ...


Oct 02, 2017, 09:00 ET Doug Sommerville of Teva Canada Elected Chair of Canadian Generic Pharmaceutical Association

Jean-Guy Goulet of Pharmascience Elected Vice Chair TORONTO, Oct. 2, 2017 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Mr. Doug Sommerville,...


Jul 16, 2017, 13:03 ET Agreement in Principle between the Government of Quebec and Canadian Generic Pharmaceutical Association (CGPA)

MONTREAL, July 16, 2017 /CNW Telbec/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the agreement in principle announced...


Jun 28, 2017, 13:38 ET Quebec's Minister of Health Must Abandon Risky Prescription Drug Tendering Scheme and Negotiate Sustainable Solution

MONTREAL, June 28, 2017 /CNW Telbec/ - The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the Government of Quebec's plan to...


Feb 27, 2017, 09:00 ET Larry MacGirr of Pharmascience Elected Chair of Canadian Generic Pharmaceutical Association

Doug Sommerville of Teva Canada Elected Vice Chair TORONTO, Feb. 27, 2017 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Mr. Larry MacGirr,...


Oct 17, 2016, 09:00 ET New Report: Regulatory Convergence Key to Ensuring Ongoing Supply of Generic Prescription Medicines in Canada

TORONTO, Oct. 17, 2016 /CNW/ - Greater regulatory convergence is needed to ensure a consistent supply of safe, effective and high-quality generic medicines in Canada, according to a new study...


Sep 12, 2016, 09:00 ET New Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Less than Half of 10% Commitment

TORONTO, Sept. 12, 2016 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada is less than half of the 10% the industry committed to when their...


Jan 11, 2016, 09:00 ET New Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Sets New Historic Low

12th Consecutive Year that 10% Commitment Has Not Been Met TORONTO, Jan. 11, 2016 /CNW/ - Brand-name drug companies' research and development spending as a percentage of sales in Canada has dropped...


Sep 14, 2015, 10:49 ET Canada Welcoming World's Generic and Biosimilar Medicines Industry

TORONTO, Sept. 14, 2015 /CNW/ - Canada is hosting the 18th Annual International Generic Pharmaceutical Alliance (IGPA) Conference from September 16 through 18, 2015 at Toronto's Westin Harbour Castle ...


Apr 07, 2015, 09:00 ET Canadian Generic Pharmaceutical Association (CGPA) Establishes First Voice for Biosimilars in Canada

TORONTO, April 7, 2015 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) announced today the establishment of a new CGPA Biosimilars Board and the election of Michel Robidoux, President...


Mar 23, 2015, 09:00 ET Jeff Watson of Apotex Elected Chair of Canadian Generic Pharmaceutical Association

Larry MacGirr of Pharmascience Elected Vice Chair TORONTO, March 23, 2015 /CNW/ - The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the election of Mr. Jeff Watson,...


Feb 10, 2015, 13:53 ET Statement from the Canadian Generic Pharmaceutical Association (CGPA)

Regarding Minister Ambrose's Announcement Regarding Shortages of Prescription Medicines TORONTO, Feb. 10, 2015 /CNW/ - The following is a statement from Jim Keon, President of the Canadian Generic...


Oct 30, 2014, 09:00 ET Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines

New Framework Provides More Predictable, Stable Environment for Payers and Manufacturers CHARLOTTETOWN, Oct. 30, 2014 /CNW/ - Atlantic Canadians will save an estimated $560-million through an...


Oct 16, 2014, 09:00 ET Canadians to Save $3.8-Billion Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines

New Framework Provides More Predictable, Stable Environment for Payers and Manufacturers TORONTO, Oct. 16, 2014 /CNW/ - Canadians will save an estimated $3.8-billion through an unprecedented...


Oct 14, 2014, 09:00 ET New Report: R&D Spending by Brand-Name Drug Companies in Canada Drops to Lowest Level in Recorded History

Providing longer market monopolies has not increased domestic R&D spending TORONTO, Oct. 14, 2014 /CNW/ - Research and development spending by brand-name drug companies in Canada has dropped to the...


Nov 04, 2013, 09:00 ET New Report Highlights 10 Years of Broken R&D Promises to Canadians by Brand-Name Drug Companies

Longer drug monopolies in Canada do not result in increased domestic R&D spending TORONTO, Nov. 4, 2013 /CNW/ - New data on pharmaceutical research and development spending in Canada provides further ...